In vitro genotoxicity of nitroimidazoles as a tool in the search of new trypanocidal agents

Von Trompowsky, Ana Claudia Manoel; Conde, Taline Ramos; Lemos, Renata Calil; Quaresma, Bruna Maria CS; Pitombeira, Marcelly Cristina SR; de Carvalho, Alcione Silva; Boechat, Núbia; Salomão, Kelly; de Castro, Solange Lisboa; Zamith, Helena Pereira da Silva.
Mem. Inst. Oswaldo Cruz ; 114: e190017, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1012676

Documentos relacionados

  1. Benzonidazole treatment has a beneficial effect on cells infected with the Colombian strain of Trypanosoma cruzi.
  2. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.
  3. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  4. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>.
  5. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
  6. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.
  7. Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice.
  8. A functional assay using human whole blood and flow cytometry analysis to evaluate cytotoxicity and immunomodulatory effect of anti-Trypanosoma cruzi drugs.
  9. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.
  10. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.